Assessment of gastrointestinal tolerability and efficacy of enteric-coated mycophenolate sodium (Myfortic) in heart transplant recipients.
Latest Information Update: 31 Jul 2020
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Heart transplant rejection
- Focus Adverse reactions
- 19 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2009 Planned end date changed from 1 Jan 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 07 Jan 2008 New trial record.